Cardiologists from NYU Langone Heart will present their latest clinical findings and research at the American College of Cardiology’s Annual Scientific Session, ACC.26, which takes place March 28 to 30 in New Orleans, according to a Mar. 27 announcement.
The presentations highlight advances in early risk identification, diagnosis, and personalized treatment strategies for cardiovascular disease. Glenn I. Fishman, MD, director of the Leon H. Charney Division of Cardiology at NYU Grossman School of Medicine, said: “These findings and presentations are a snapshot of the research our teams are advancing, with a focus on earlier risk identification, more accurate diagnosis, and more tailored treatment strategies.” Fishman also said: “Together, this work reflects a broader shift toward more proactive, personalized, and multidisciplinary cardiovascular care.”
Among the topics presented is research from NYU Langone’s Postpartum Cardiovascular Health Program that found people who experience high blood pressure during pregnancy may face increased long-term heart risks. Anais Hausvater, MD said: “Pregnancy can act as an early warning sign for future heart disease… This is a critical window to identify risk early and help patients protect their long-term heart health.” Another study identified that cardiac amyloidosis can be present even when not suspected based on routine testing among patients undergoing surgery for hypertrophic cardiomyopathy. Daniele Massera, MD said: “Recognizing when these conditions overlap is critical especially as targeted treatments become more widely available.”
Additional presentations include approaches allowing some cancer patients to continue important therapies despite cardiac side effects if monitored closely—a strategy described by Michelle Bloom, MD as about “finding the right balance—treating the cancer while protecting the heart.” Research into bioprosthetic heart valves found they may wear out faster in younger patients or fail differently depending on underlying conditions; Dan G. Halpern, MD said selection should consider limited durability influenced by specific causes.
NYU Langone faculty will participate in over 60 sessions during ACC.26 covering these studies and others related to advancements in cardiovascular care.
